Back

Answers in CME Inc. (AiCME)

  • Androgens
  • Prostatic Neoplasms

Getting to the Heart of Prostate Cancer: Identifying and Managing Cardiovascular Risk in Patients Receiving Androgen-Deprivation Therapy

This enduring activity showcases a multiprofessional panel and aims to improve clinicians’ management of ADT-related side affects, including CV risks for patients with prostate cancer. As a result of this educational curriculum, learners will be better able to: 1. Evaluate the impacts of prostate cancer and ADT on cardiovascular risk; 2. Translate the latest research for cardiovascular management of patients on ADT to clinical practice; and, 3. Design personalized treatment approaches to optimize ADT across treatment settings. Learners have access to downloadable materials for continued practice. CME and MOC credits offered.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Microlearning
  • includes Online course / module
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Oct 9, 2026
  • Last day to claim credit
    Oct 9, 2027 12 months left